Summary
=======

A 68-year-old man with a severe ischemic cardiomyopathy underwent left ventricular assist device (LVAD) implantation (Heart Mate II device) for destination therapy. He presented 49 months after LVAD implantation with worsening heart failure symptoms and new severe aortic regurgitation. Given high risk for both surgical and transcatheter aortic valve replacement, he was admitted for transcatheter closure of the aortic valve under transesophageal echocardiographic (TEE) guidance. TEE imaging revealed severe aortic regurgitation ([Fig. 1A](#fig1){ref-type="fig"} and [B](#fig1){ref-type="fig"} and [Videos 1](#SM1){ref-type="supplementary-material"} and [2](#SM2){ref-type="supplementary-material"}). Under TEE and fluoroscopic guidance, a 25 mm Amplatzer cribriform atrial septal defect closure device was advanced across the aortic valve ([Fig. 1C](#fig1){ref-type="fig"} and [D](#fig1){ref-type="fig"} and [Videos 3](#SM3){ref-type="supplementary-material"} and [4](#SM4){ref-type="supplementary-material"}). Immediately after device deployment, TEE revealed a well-seated device with complete aortic valve closure and trivial aortic regurgitation ([Fig. 2A](#fig2){ref-type="fig"}, [B](#fig2){ref-type="fig"}, [C](#fig2){ref-type="fig"} and [D](#fig2){ref-type="fig"} and [Videos 5](#SM5){ref-type="supplementary-material"}, [6](#SM6){ref-type="supplementary-material"}, [7](#SM7){ref-type="supplementary-material"} and [8](#SM8){ref-type="supplementary-material"}). Subsequent transthoracic echocardiograms obtained from 74 to 172 days after the procedure revealed no residual aortic regurgitation. The patient awoke with diffuse urticaria 244 days after the procedure and died en route to the emergency department, presumably secondary to a systemic allergic reaction. *De novo* aortic regurgitation is increasingly recognized in patients with LVADs ([@bib1]). TEE-guided transcatheter aortic valve closure is an option in these high-risk patients ([@bib2]). Figure 1(A) Mid-esophageal long-axis image revealing severe aortic regurgitation (white arrow). (B) Mid-esophageal short-axis image demonstrating severe central aortic regurgitation (white arrow). (C) Mid-esophageal long-axis image showing the right atrial disc of the Amplatzer cribriform atrial septal defect closure device in the left ventricle (white arrow). (D) Mid-esophageal long-axis image showing the right atrial disc of the Amplatzer cribriform atrial septal defect closure device in the left ventricle (white arrow), and the left atrial disc in the ascending aorta. Figure 2(A) Mid-esophageal short-axis image after device deployment with a closed aortic valve (white arrow). (B) Mid-esophageal long-axis image after device deployment with a closed aortic valve (white arrow). (C) Mid-esophageal long-axis image revealing trivial aortic regurgitation (with minimal flow between the 2 device discs) (white arrow). (D) Three-dimensional en face view (ascending aorta perspective) after device deployment. Video 1Mid-esophageal long-axis image revealing severe aortic regurgitation. View Video 1 at <http://movie-usa.glencoesoftware.com/video/10.1530/ERP-17-0006/video-1>.Download Video 1 Video 2Mid-esophageal short-axis image demonstrating severe central aortic regurgitation. View Video 2 at <http://movie-usa.glencoesoftware.com/video/10.1530/ERP-17-0006/video-2>.Download Video 2 Video 3Mid-esophageal long-axis image showing the right atrial disc of the Amplatzer cribriform atrial septal defect closure device in the left ventricle. View Video 3 at <http://movie-usa.glencoesoftware.com/video/10.1530/ERP-17-0006/video-3>.Download Video 3 Video 4Mid-esophageal long-axis image showing the right atrial disc of the Amplatzer cribiform atrial septal defect closure device in the left ventricle, and the left atrial disc in the ascending aorta. View Video 4 at <http://movie-usa.glencoesoftware.com/video/10.1530/ERP-17-0006/video-4>.Download Video 4 Video 5Mid-esophageal short-axis image after device deployment with a closed aortic valve. View Video 5 at <http://movie-usa.glencoesoftware.com/video/10.1530/ERP-17-0006/video-5>.Download Video 5 Video 6Mid-esophageal long-axis image after device deployment with a closed aortic valve. View Video 6 at <http://movie-usa.glencoesoftware.com/video/10.1530/ERP-17-0006/video-6>.Download Video 6 Video 7Mid-esophageal long-axis image revealing trivial aortic regurgitation (with minimal flow between the 2 device discs). View Video 7 at <http://movie-usa.glencoesoftware.com/video/10.1530/ERP-17-0006/video-7>.Download Video 7 Video 8Three-dimensional en face view (ascending aorta perspective) after device deployment. View Video 8 at <http://movie-usa.glencoesoftware.com/video/10.1530/ERP-17-0006/video-8>.Download Video 8
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